Health technology assessment of drugs for rare diseases: insights, trends, and reasons for negative recommendations from the CADTH common drug review (Q28069381)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Health technology assessment of drugs for rare diseases: insights, trends, and reasons for negative recommendations from the CADTH common drug review
scientific article

    Statements

    instance of
    review article
    3 references
    stated in
    PubMed
    retrieved
    30 June 2019
    stated in
    PubMed
    retrieved
    1 September 2020
    stated in
    PubMed
    retrieved
    2 December 2020
    title
    Health technology assessment of drugs for rare diseases: insights, trends, and reasons for negative recommendations from the CADTH common drug review (English)
    1 reference
    stated in
    PubMed
    publication date
    1 December 2016
    4 references
    stated in
    PubMed
    stated in
    PubMed Central
    retrieved
    30 June 2019
    stated in
    PubMed Central
    retrieved
    1 September 2020
    stated in
    PubMed Central
    retrieved
    2 December 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q28069381&oldid=1613801171"